{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:55:27Z","timestamp":1792173327365,"version":"4.4.0"},"reference-count":113,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Glioblastoma (GBM) remains one of the most aggressive and treatment-resistant brain tumors, necessitating innovative therapeutic approaches. Polymer-based nanotechnology has emerged as a promising solution, offering precise drug delivery, enhanced blood-brain barrier (BBB) penetration, and adaptability to the tumor microenvironment (TME). This review explores the diverse applications of polymeric nanoparticles (NPs) in GBM treatment, including delivery of chemotherapeutics, targeted therapeutics, immunotherapeutics, and other agents for radiosensitization and photodynamic therapy. Recent advances in targeted delivery and multifunctional polymer highlight their potential to overcome the challenges that GBM brought, such as heterogeneity of the tumor, BBB limitation, immunosuppressive TME, and consideration of biocompatibility and safety. Meanwhile, the future directions to address these challenges are also proposed. By addressing these obstacles, polymer-based nanotechnology represents a transformative strategy for improving GBM treatment outcomes, paving the way for more effective and patient-specific therapies.<\/jats:p>","DOI":"10.3389\/fphar.2024.1519479","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T23:20:02Z","timestamp":1736119202000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Applications of polymeric nanoparticles in drug delivery for glioblastoma"],"prefix":"10.3389","volume":"15","author":[{"given":"Shuhan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.3390\/pharmaceutics16101344","article-title":"Nanomaterial-enhanced microneedles: emerging therapies for diabetes and obesity","volume":"16","author":"Abbasi","year":"2024","journal-title":"Pharmaceutics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"102270","DOI":"10.1016\/j.nano.2020.102270","article-title":"Nano delivery of natural substances as prospective autophagy modulators in glioblastoma","volume":"29","author":"Agarwal","year":"2020","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2020.01.011","article-title":"Targeting cancer cells with nanotherapeutics and nanodiagnostics: current status and future perspectives","volume":"69","author":"Ali","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/cad.0000000000001065","article-title":"Targeted polymeric nanoparticle for anthracycline delivery in hypoxia-induced drug resistance in metastatic breast cancer cells","volume":"32","author":"Almoustafa","year":"2021","journal-title":"Anticancer Drugs"},{"key":"B5","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3390\/pharmaceutics16070931","article-title":"pH-triggered hydrogel nanoparticles for efficient anticancer drug delivery and bioimaging applications","volume":"16","author":"Amin","year":"2024","journal-title":"Pharmaceutics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3390\/pharmaceutics16081092","article-title":"Formulation of polymeric nanoparticles loading baricitinib as a topical approach in ocular application","volume":"16","author":"Beirampour","year":"2024","journal-title":"Pharmaceutics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.3390\/cancers15133427","article-title":"Photodynamic therapy for glioblastoma: illuminating the path toward clinical applicability","volume":"15","author":"Bhanja","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"134777","DOI":"10.1016\/j.ijbiomac.2024.134777","article-title":"Advancing glioblastoma treatment through iron metabolism: a focus on TfR1 and Ferroptosis innovations","volume":"278","author":"Caverzan","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.3390\/ijms25126733","article-title":"Recurrent glioblastoma-molecular underpinnings and evolving treatment paradigms","volume":"25","author":"Chang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"eaax4690","DOI":"10.1126\/sciadv.aax4690","article-title":"Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9(+) T cells","volume":"6","author":"Chen","year":"2020","journal-title":"Sci. Adv."},{"key":"B11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.colsurfb.2019.05.042","article-title":"Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer","volume":"181","author":"Cheng","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12951-020-00684-5","article-title":"Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme","volume":"18","author":"Choi","year":"2020","journal-title":"J. Nanobiotechnology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2217\/nnm-2021-0348","article-title":"A review of recent advances in magnetic nanoparticle-based theranostics of glioblastoma","volume":"17","author":"Dhar","year":"2022","journal-title":"Nanomedicine (Lond)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s13205-023-03901-8","article-title":"Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications","volume":"14","author":"Dhayalan","year":"2024","journal-title":"Biotech."},{"key":"B15","doi-asserted-by":"publisher","first-page":"102398","DOI":"10.1016\/j.nantod.2024.102398","article-title":"Neutrophil-based Trojan horse containing polymer nano-therapeutics for sono-activatable ferroptosis-immunotherapy of orthotopic glioma","volume":"57","author":"Ding","year":"2024","journal-title":"Nano Today"},{"key":"B16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/jbm.b.34157","article-title":"Nanoentrapped polyphenol coating for sustained drug release from a balloon catheter","volume":"107","author":"Dugas","year":"2019","journal-title":"J. Biomed. Mater Res. B Appl. Biomater."},{"key":"B17","doi-asserted-by":"publisher","first-page":"105850","DOI":"10.1016\/j.jddst.2024.105850","article-title":"Advances in targeted nano-delivery of bevacizumab using nanoparticles: current insights, innovations, and future perspectives","volume":"98","author":"Fatima","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3390\/pharmaceutics16091172","article-title":"Exploring protein-based carriers in drug delivery: a review","volume":"16","author":"Ferraro","year":"2024","journal-title":"Pharmaceutics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e00723","DOI":"10.1002\/prp2.723","article-title":"Biological drug therapy for ocular angiogenesis: anti-VEGF agents and novel strategies based on nanotechnology","volume":"9","author":"Formica","year":"2021","journal-title":"Pharmacol. Res. and Perspect."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.2174\/0929867329666221006113536","article-title":"A revision of polymeric nanoparticles as a strategy to improve the biological activity of melatonin","volume":"30","author":"Franco","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.16966\/2470-3206.116","article-title":"Targeting cancer using polymeric nanoparticle mediated combination chemotherapy","volume":"2","author":"Gad","year":"2016","journal-title":"Int. J. Nanomed Nanosurg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1080\/17425247.2020.1810015","article-title":"Nanoparticle-mediated therapeutic compounds delivery to glioblastoma","volume":"17","author":"Gallego","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"B23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/pharmaceutics16040481","article-title":"Nasal delivery to the brain: harnessing nanoparticles for effective drug transport","volume":"16","author":"Gandhi","year":"2024","journal-title":"Pharmaceutics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3390\/biomedicines12081822","article-title":"Current non-metal nanoparticle-based therapeutic approaches for glioblastoma treatment","volume":"12","author":"Gawel","year":"2024","journal-title":"Biomedicines"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.3390\/polym16172536","article-title":"Biodegradable polymeric nanoparticle-based drug delivery systems: comprehensive overview, perspectives and challenges","volume":"16","author":"Geszke-Moritz","year":"2024","journal-title":"Polym. (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s13287-022-03212-4","article-title":"Mesenchymal stem cell-derived exosomes as a new therapeutic strategy in the brain tumors","volume":"13","author":"Ghasempour","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3390\/pharmaceutics16091202","article-title":"Recent advancements in gallic acid-based drug delivery: applications, clinical trials, and future directions","volume":"16","author":"Harwansh","year":"2024","journal-title":"Pharmaceutics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejpb.2018.06.004","article-title":"Design and evaluation of a CXCR4 targeting peptide 4DV3 as an HIV entry inhibitor and a ligand for targeted drug delivery","volume":"138","author":"Heon Lee","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B29","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jconrel.2015.10.006","article-title":"Control of polymeric nanoparticle size to improve therapeutic delivery","volume":"219","author":"Hickey","year":"2015","journal-title":"J. Control Release"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/j.biomaterials.2011.11.072","article-title":"Amphiphilic micelles of poly(2-methyl-2-carboxytrimethylene carbonate-co-D,L-lactide)-graft-poly(ethylene glycol) for anti-cancer drug delivery to solid tumours","volume":"33","author":"Ho","year":"2012","journal-title":"Biomaterials"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.3390\/pharmaceutics16101246","article-title":"An efficient fabrication approach for multi-cancer responsive chemoimmuno Co-delivery nanoparticles","volume":"16","author":"Huang","year":"2024","journal-title":"Pharmaceutics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1016\/j.xphs.2020.06.021","article-title":"Development of brain targeting peptide based MMP-9 inhibiting nanoparticles for the treatment of brain diseases with elevated MMP-9 activity","volume":"109","author":"Islam","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","article-title":"A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity","volume":"180","author":"Jacob","year":"2020","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s13346-019-00679-2","article-title":"Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme","volume":"10","author":"Jena","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"ii24","DOI":"10.1093\/neuonc\/nou355","article-title":"Sui generis: gene therapy and delivery systems for the treatment of glioblastoma","volume":"17","author":"Kane","year":"2015","journal-title":"Neuro Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40580-018-0168-8","article-title":"Therapeutic nanoplatforms and delivery strategies for neurological disorders","volume":"5","author":"Kang","year":"2018","journal-title":"Nano Converg."},{"key":"B37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jconrel.2016.02.026","article-title":"Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art","volume":"227","author":"Karim","year":"2016","journal-title":"J. Control Release"},{"key":"B38","doi-asserted-by":"publisher","first-page":"113999","DOI":"10.1016\/j.addr.2021.113999","article-title":"Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies","volume":"179","author":"Karlsson","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1209168","DOI":"10.3389\/fonc.2023.1209168","article-title":"Secretome profiling of Artemisia absinthium extract-loaded polymeric nanoparticle-treated MCF-7 and MDA-MB-231 revealed perturbation in microtubule assembly and cell migration","volume":"13","author":"Kauser","year":"2023","journal-title":"Front. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.semcancer.2022.06.007","article-title":"Nanomedicine for glioblastoma: progress and future prospects","volume":"86","author":"Khan","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.actbio.2020.12.015","article-title":"Molecular design of a high-performance polymeric carrier for delivery of a variety of boronic acid-containing drugs","volume":"121","author":"Kim","year":"2021","journal-title":"Acta Biomater."},{"key":"B42","doi-asserted-by":"publisher","first-page":"30544","DOI":"10.1021\/acsomega.4c02258","article-title":"Core-tunable dendritic polymer: a folate-guided theranostic nanoplatform for drug delivery applications","volume":"9","author":"Koti","year":"2024","journal-title":"ACS Omega"},{"key":"B43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-022-01298-0","article-title":"Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence","volume":"15","author":"Kreatsoulas","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0169-409x(00)00122-8","article-title":"Nanoparticulate systems for brain delivery of drugs","volume":"47","author":"Kreuter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jconrel.2019.12.041","article-title":"Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: an up-to-date review","volume":"319","author":"Kumari","year":"2020","journal-title":"J. Control. Release"},{"key":"B46","doi-asserted-by":"publisher","first-page":"188999","DOI":"10.1016\/j.bbcan.2023.188999","article-title":"Emerging trends in post-translational modification: shedding light on Glioblastoma multiforme","volume":"1878","author":"Kumari","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3390\/ma17051153","article-title":"Designing gold nanoparticles for precise glioma treatment: challenges and alternatives","volume":"17","author":"Lansangan","year":"2024","journal-title":"Mater. (Basel)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.semcancer.2021.02.014","article-title":"Cancer cell heterogeneity and plasticity in glioblastoma and brain tumors","volume":"82","author":"Lauko","year":"2022","journal-title":"Seminars Cancer Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"243","DOI":"10.7150\/ntno.65544","article-title":"Anti-PD-L1 F(ab) conjugated PEG-PLGA nanoparticle enhances immune checkpoint therapy","volume":"6","author":"Lee","year":"2022","journal-title":"Nanotheranostics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"101896","DOI":"10.1016\/j.ctrv.2019.101896","article-title":"Molecular targeted therapy of glioblastoma","volume":"80","author":"Le Rhun","year":"2019","journal-title":"Cancer Treat. Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fphar.2017.00051","article-title":"Drug-loaded polymeric nanoparticles for cancer stem cell targeting","volume":"8","author":"Li","year":"","journal-title":"Front. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jconrel.2017.05.025","article-title":"Singlet oxygen-responsive micelles for enhanced photodynamic therapy","volume":"260","author":"Li","year":"","journal-title":"J. Control. Release"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.2147\/ijn.S450853","article-title":"Nanoparticle-based combinational strategies for overcoming the blood-brain barrier and blood-tumor barrier","volume":"19","author":"Lim","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e10483","DOI":"10.1002\/btm2.10483","article-title":"Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme","volume":"8","author":"Lim","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"101067","DOI":"10.1016\/j.mtbio.2024.101067","article-title":"Enhancing glioma-specific drug delivery through self-assembly of macrophage membrane and targeted polymer assisted by low-frequency ultrasound irradiation","volume":"26","author":"Lin","year":"","journal-title":"Mater. Today Bio"},{"key":"B56","doi-asserted-by":"publisher","first-page":"101067","DOI":"10.1016\/j.mtbio.2024.101067","article-title":"Enhancing glioma-specific drug delivery through self-assembly of macrophage membrane and targeted polymer assisted by low-frequency ultrasound irradiation","volume":"26","author":"Lin","year":"","journal-title":"Mater Today Bio"},{"key":"B57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41586-023-06623-2","article-title":"Clinical trial links oncolytic immunoactivation to survival in glioblastoma","volume":"623","author":"Ling","year":"2023","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1021\/acsbiomaterials.8b00260","article-title":"Development of novel lignin-based targeted polymeric nanoparticle platform for efficient delivery of anticancer drugs","volume":"4","author":"Liu","year":"2018","journal-title":"ACS Biomater. Sci. Eng."},{"key":"B59","doi-asserted-by":"publisher","first-page":"121645","DOI":"10.1016\/j.biomaterials.2022.121645","article-title":"An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy","volume":"287","author":"Liu","year":"","journal-title":"Biomaterials"},{"key":"B60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s11671-022-03668-6","article-title":"Nanoscale drug delivery systems in glioblastoma","volume":"17","author":"Liu","year":"","journal-title":"Nanoscale Res. Lett."},{"key":"B61","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/pharmaceutics15030746","article-title":"Intranasal polymeric and lipid-based nanocarriers for CNS drug delivery","volume":"15","author":"Maher","year":"2023","journal-title":"Pharmaceutics"},{"key":"B62","doi-asserted-by":"publisher","first-page":"6473","DOI":"10.3390\/molecules27196473","article-title":"Biomimetic targeted theranostic nanoparticles for breast cancer treatment","volume":"27","author":"Marshall","year":"2022","journal-title":"Molecules"},{"key":"B63","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ijpharm.2017.07.049","article-title":"Breaching barriers in glioblastoma. Part II: targeted drug delivery and lipid nanoparticles","volume":"531","author":"Miranda","year":"2017","journal-title":"Int. J. Pharm."},{"key":"B64","first-page":"3742","article-title":"Extracellular matrix in glioblastoma: opportunities for emerging therapeutic approaches","volume":"11","author":"Mohiuddin","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/pharmaceutics16091226","article-title":"Magnetic nanoparticles with on-site azide and alkyne functionalized polymer coating in a single step through a solvothermal process","volume":"16","author":"Mora-Cabello","year":"2024","journal-title":"Pharmaceutics"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e09517","DOI":"10.1016\/j.heliyon.2022.e09517","article-title":"Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities","volume":"8","author":"Morales","year":"2022","journal-title":"Heliyon"},{"key":"B67","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1039\/d4bm00665h","article-title":"Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment","volume":"12","author":"Mu","year":"2024","journal-title":"Biomater. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1080\/03639045.2020.1821053","article-title":"Development of polymeric nanoparticle gel prepared with the combination of ionic pre-gelation and polyelectrolyte complexation as a novel drug delivery of timolol maleate","volume":"46","author":"Muhtadi","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"B69","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.trsl.2012.11.003","article-title":"Current status of gene therapy for brain tumors","volume":"161","author":"Murphy","year":"2013","journal-title":"Transl. Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jconrel.2014.06.031","article-title":"Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound","volume":"189","author":"Nance","year":"2014","journal-title":"J. Control Release"},{"key":"B71","doi-asserted-by":"publisher","first-page":"117372","DOI":"10.1016\/j.biopha.2024.117372","article-title":"Biophysical translational paradigm of polymeric nanoparticle: embarked advancement to brain tumor therapy","volume":"179","author":"Naser","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.3390\/cancers13143387","article-title":"Polyester polymeric nanoparticles as platforms in the development of novel nanomedicines for cancer treatment","volume":"13","author":"Niza","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.msec.2019.02.009","article-title":"A multilayer hollow nanocarrier for pulmonary co-drug delivery of methotrexate and doxorubicin in the form of dry powder inhalation formulation","volume":"99","author":"Nozohouri","year":"2019","journal-title":"Mater Sci. Eng. C Mater Biol. Appl."},{"key":"B74","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1021\/acsnano.3c09700","article-title":"Nanoparticle-conjugated toll-like receptor 9 agonists improve the potency, durability, and breadth of COVID-19 vaccines","volume":"18","author":"Ou","year":"2024","journal-title":"ACS Nano"},{"key":"B75","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fphys.2018.00170","article-title":"Advances in glioblastoma multiforme treatment: new models for nanoparticle therapy","volume":"9","author":"Ozdemir-Kaynak","year":"2018","journal-title":"Front. Physiol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3390\/pharmaceutics12121198","article-title":"Nanodelivery systems targeting epidermal growth factor receptors for glioma management","volume":"12","author":"Paranthaman","year":"2020","journal-title":"Pharmaceutics"},{"key":"B77","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ajps.2020.04.001","article-title":"BioPerine encapsulated nanoformulation for overcoming drug-resistant breast cancers","volume":"15","author":"Pillai","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1021\/bm501028c","article-title":"Click conjugation of peptide to hydrogel nanoparticles for tumor-targeted drug delivery","volume":"15","author":"Qin","year":"2014","journal-title":"Biomacromolecules"},{"key":"B79","doi-asserted-by":"publisher","first-page":"14191","DOI":"10.1021\/acsanm.3c02122","article-title":"Transferrin-conjugated PLGA nanoparticles for Co-delivery of temozolomide and bortezomib to glioblastoma cells","volume":"6","author":"Ramalho","year":"2023","journal-title":"ACS Appl. Nano Mater"},{"key":"B80","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2174\/1389200221666200508074348","article-title":"Polymeric nanoparticles for brain drug delivery - a review","volume":"21","author":"Raman","year":"2020","journal-title":"Curr. Drug Metab."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/s41565-019-0568-x","article-title":"A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain","volume":"14","author":"Ram\u00edrez-Garc\u00eda","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/jpm13091328","article-title":"Nanoparticle-based treatment in glioblastoma","volume":"13","author":"Roque","year":"2023","journal-title":"J. Pers. Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3390\/biom11081131","article-title":"Transportation of single-domain antibodies through the blood-brain barrier","volume":"11","author":"Ruiz-L\u00f3pez","year":"2021","journal-title":"Biomolecules"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/pharmaceutics14081566","article-title":"Nanocarriers: a reliable tool for the delivery of anticancer drugs","volume":"14","author":"Sabit","year":"2022","journal-title":"Pharmaceutics"},{"key":"B85","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.3390\/polym13244400","article-title":"Polymeric nanoparticles: exploring the current drug development and therapeutic insight of breast cancer treatment and recommendations","volume":"13","author":"Sartaj","year":"2021","journal-title":"Polym. (Basel)"},{"key":"B86","doi-asserted-by":"publisher","first-page":"135923","DOI":"10.1016\/j.ijbiomac.2024.135923","article-title":"Targeting inflammation with hyaluronic acid-based micro- and nanotechnology: a disease-oriented review","volume":"280","author":"Senobari","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2300157","DOI":"10.1002\/macp.202300157","article-title":"Poly(N-isopropylacrylamide)-Based polymers: recent overview for the development of temperature-responsive drug delivery and biomedical applications","volume":"224","author":"Shaibie","year":"2023","journal-title":"Macromol. Chem. Phys."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3390\/pharmaceutics16101305","article-title":"Stable polymer-lipid hybrid nanoparticles based on mcl-polyhydroxyalkanoate and cationic liposomes for mRNA delivery","volume":"16","author":"Shishlyannikov","year":"2024","journal-title":"Pharmaceutics"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/pharmaceutics16101275","article-title":"Annatto (bixa orellana)-based nanostructures for biomedical applications-A systematic review","volume":"16","author":"Silva","year":"2024","journal-title":"Pharmaceutics"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e2306230","DOI":"10.1002\/advs.202306230","article-title":"Enzyme-responsive branched glycopolymer-based nanoassembly for Co-delivery of paclitaxel and akt inhibitor toward synergistic therapy of gastric cancer","volume":"11","author":"Song","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2217\/17435889.3.4.495","article-title":"Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles","volume":"3","author":"Sun","year":"2008","journal-title":"Nanomedicine (Lond)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1038\/s41467-022-32837-5","article-title":"Bacteria loaded with glucose polymer and photosensitive ICG silicon-nanoparticles for glioblastoma photothermal immunotherapy","volume":"13","author":"Sun","year":"2022","journal-title":"Nat. Commun."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1039\/c8cs00805a","article-title":"Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics","volume":"48","author":"Tang","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"B94","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1021\/acsnano.3c00269","article-title":"Radiation-triggered selenium-engineered mesoporous silica nanocapsules for RNAi therapy in radiotherapy-resistant glioblastoma","volume":"17","author":"Tang","year":"2023","journal-title":"ACS Nano"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3390\/pharmaceutics16101315","article-title":"Clindamycin-loaded polyhydroxyalkanoate nanoparticles for the treatment of methicillin-resistant Staphylococcus aureus-infected wounds","volume":"16","author":"Ullah","year":"2024","journal-title":"Pharmaceutics"},{"key":"B96","doi-asserted-by":"publisher","first-page":"27832","DOI":"10.1021\/acsomega.4c02234","article-title":"Enhancing therapeutic efficacy in cancer treatment: integrating nanomedicine with autophagy inhibition strategies","volume":"9","author":"Walweel","year":"2024","journal-title":"ACS Omega"},{"key":"B97","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1039\/d3nr05195a","article-title":"Sensitizing chemotherapy for glioma with fisetin mediated by a microenvironment-responsive nano-drug delivery system","volume":"16","author":"Wang","year":"","journal-title":"Nanoscale"},{"key":"B98","doi-asserted-by":"publisher","first-page":"122187","DOI":"10.1016\/j.biomaterials.2023.122187","article-title":"Maleimide as the PEG end-group promotes macrophage-targeted drug delivery of PEGylated nanoparticles in vivo by enhancing interaction with circulating erythrocytes","volume":"300","author":"Wang","year":"","journal-title":"Biomaterials"},{"key":"B99","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41578-019-0135-y","article-title":"Dissecting and rebuilding the glioblastoma microenvironment with engineered materials","volume":"4","author":"Wolf","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"B100","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.7150\/thno.53828","article-title":"Biocompatible AIEgen\/p-glycoprotein siRNA@reduction-sensitive paclitaxel polymeric prodrug nanoparticles for overcoming chemotherapy resistance in ovarian cancer","volume":"11","author":"Wu","year":"2021","journal-title":"Theranostics"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1024143","DOI":"10.3389\/fbioe.2022.1024143","article-title":"Polymeric nanoparticles-Promising carriers for cancer therapy","volume":"10","author":"Xiao","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bioactmat.2023.04.005","article-title":"A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy","volume":"27","author":"Xu","year":"2023","journal-title":"Bioact. Mater"},{"key":"B103","doi-asserted-by":"publisher","first-page":"e202402291","DOI":"10.1002\/anie.202402291","article-title":"A polymeric nanoparticle to Co-deliver mitochondria-targeting peptides and Pt(IV) prodrug: toward high loading efficiency and combination efficacy","volume":"63","author":"Yang","year":"2024","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B104","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.1038\/s41467-022-34462-8","article-title":"Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"B105","doi-asserted-by":"publisher","first-page":"e2309314","DOI":"10.1002\/advs.202309314","article-title":"Lipid-polymer nanoparticles mediate compartmentalized delivery of Cas9 and sgRNA for glioblastoma vasculature and immune reprogramming","volume":"11","author":"Zhang","year":"","journal-title":"Adv. Sci. (Weinh)"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2003937","DOI":"10.1002\/advs.202003937","article-title":"Development of polymeric nanoparticles for blood-brain barrier transfer-strategies and challenges","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"B107","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.1021\/acsami.6b16500","article-title":"Cisplatin cross-linked multifunctional nanodrugplexes for combination therapy","volume":"9","author":"Zhang","year":"2017","journal-title":"ACS Appl. Mater Interfaces"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1021\/acs.nanolett.7b05263","article-title":"Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett."},{"key":"B109","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jconrel.2024.07.073","article-title":"Designing intelligent bioorthogonal nanozymes: recent advances of stimuli-responsive catalytic systems for biomedical applications","volume":"373","author":"Zhang","year":"","journal-title":"J. Control. Release"},{"key":"B110","doi-asserted-by":"publisher","first-page":"8674","DOI":"10.1021\/acs.nanolett.3c02514","article-title":"Molecularly imprinted nanomedicine for anti-angiogenic cancer therapy via blocking vascular endothelial growth factor signaling","volume":"23","author":"Zhao","year":"2023","journal-title":"Nano Lett."},{"key":"B111","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"B112","doi-asserted-by":"publisher","first-page":"113887","DOI":"10.1016\/j.addr.2021.113887","article-title":"Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases","volume":"176","author":"Zu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B113","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1021\/mp200367s","article-title":"Hydrogels as intracellular depots for drug delivery","volume":"9","author":"Zubris","year":"2012","journal-title":"Mol. Pharm."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1519479\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T23:20:08Z","timestamp":1736119208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1519479\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":113,"alternative-id":["10.3389\/fphar.2024.1519479"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1519479","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"article-number":"1519479"}}